PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $246,270 | -69.4% | 111,434 | -64.8% | 0.00% | – |
| Q1 2023 | $804,794 | +205.8% | 316,848 | +125.1% | 0.00% | – |
| Q4 2022 | $263,169 | -47.9% | 140,732 | -28.4% | 0.00% | – |
| Q3 2022 | $505,000 | +24.7% | 196,690 | -6.0% | 0.00% | – |
| Q2 2022 | $405,000 | +41.6% | 209,244 | +116.6% | 0.00% | – |
| Q1 2022 | $286,000 | -15.9% | 96,626 | +27.5% | 0.00% | – |
| Q4 2021 | $340,000 | -57.2% | 75,771 | -53.8% | 0.00% | – |
| Q3 2021 | $795,000 | -22.1% | 163,833 | +9.5% | 0.00% | – |
| Q2 2021 | $1,020,000 | -39.0% | 149,659 | -36.8% | 0.00% | – |
| Q1 2021 | $1,671,000 | +144.3% | 236,802 | +116.7% | 0.00% | – |
| Q4 2020 | $684,000 | -76.9% | 109,273 | -80.0% | 0.00% | -100.0% |
| Q3 2020 | $2,956,000 | -17.3% | 546,456 | -20.2% | 0.00% | 0.0% |
| Q2 2020 | $3,574,000 | +3510.1% | 684,823 | +2096.9% | 0.00% | – |
| Q1 2020 | $99,000 | -60.7% | 31,172 | -50.2% | 0.00% | – |
| Q4 2019 | $252,000 | +63.6% | 62,540 | +74.9% | 0.00% | – |
| Q3 2019 | $154,000 | +57.1% | 35,751 | +44.4% | 0.00% | – |
| Q2 2019 | $98,000 | -57.2% | 24,753 | -41.8% | 0.00% | – |
| Q1 2019 | $229,000 | -52.1% | 42,553 | -54.2% | 0.00% | – |
| Q4 2018 | $478,000 | -48.0% | 92,988 | -1.9% | 0.00% | – |
| Q3 2018 | $920,000 | -22.0% | 94,835 | -18.0% | 0.00% | – |
| Q2 2018 | $1,180,000 | -55.9% | 115,618 | -43.9% | 0.00% | -100.0% |
| Q1 2018 | $2,677,000 | -13.9% | 205,933 | +18.6% | 0.00% | 0.0% |
| Q4 2017 | $3,109,000 | -17.8% | 173,678 | +15.2% | 0.00% | 0.0% |
| Q3 2017 | $3,783,000 | +11.4% | 150,710 | +6.9% | 0.00% | 0.0% |
| Q2 2017 | $3,396,000 | -43.0% | 140,923 | -54.5% | 0.00% | 0.0% |
| Q1 2017 | $5,956,000 | +225.1% | 309,386 | +160.2% | 0.00% | – |
| Q4 2016 | $1,832,000 | +1439.5% | 118,900 | +1208.2% | 0.00% | – |
| Q3 2016 | $119,000 | -38.3% | 9,089 | -34.4% | 0.00% | – |
| Q2 2016 | $193,000 | +264.2% | 13,849 | +301.1% | 0.00% | – |
| Q1 2016 | $53,000 | -5.4% | 3,453 | +16.2% | 0.00% | – |
| Q4 2015 | $56,000 | -5.1% | 2,971 | -4.8% | 0.00% | – |
| Q3 2015 | $59,000 | -27.2% | 3,122 | -1.3% | 0.00% | – |
| Q2 2015 | $81,000 | -81.2% | 3,164 | -77.0% | 0.00% | – |
| Q1 2015 | $430,000 | -54.2% | 13,750 | -43.5% | 0.00% | – |
| Q4 2014 | $938,000 | – | 24,324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 3,387,172 | $6,537,000 | 1.72% |
| Worth Venture Partners, LLC | 969,698 | $2,366,000 | 1.39% |
| Omega Fund Management, LLC | 1,971,241 | $3,804,000 | 1.21% |
| Telemetry Investments, L.L.C. | 495,000 | $955,000 | 1.13% |
| CM Management, LLC | 350,000 | $676,000 | 0.72% |
| Bruce & Co., Inc. | 1,557,312 | $3,005,000 | 0.71% |
| Trellus Management Company, LLC | 295,000 | $569,000 | 0.69% |
| Abingworth LLP | 1,041,131 | $1,999,000 | 0.64% |
| 1492 Capital Management LLC | 489,376 | $944,000 | 0.62% |
| GENERAL AMERICAN INVESTORS CO INC | 1,752,470 | $3,382,000 | 0.34% |